Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world.

Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.

Cardiome Pharma was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Number of employees : 75 persons.
Sales per Businesses
20122013Delta
CAD (in Million)%CAD (in Million)%
Pharmaceutical Product Development0.789100%4.65100% +83.03%
Sales per Regions
2013
CAD (in Million)%
Rest of the World2.6957.9%
Europe1.9542.1%
Managers
NameAgeSinceTitle
William L. Hunter, MD512007President, Chief Executive Officer & Director
Robert W. Rieder, MBA681997Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Jennifer Archibald-2006Chief Financial Officer
Richard M. Glickman, PhD562006Lead Independent Director
Harold H. Shlevin, PhD642004Independent Director
Peter W. Roberts, CPA702005Independent Director
William James O'Shea642014Director
Jürgen Polifka, PhD-2013General Manager-European Sales & Marketing
Karim F. Lalji-2006Chief Commercial Officer
Shareholders
NameShares%
Fidelity Management & Research Co. 1,595,312 9.66%
FIG LLC (Private Equity) 981,596 5.94%
Adage Capital Management LP 950,000 5.75%
Putnam Investment Management LLC 923,281 5.59%
Westfield Capital Management Co. LP 730,926 4.42%
William L. Hunter, MD 510,000 3.09%
Clough Capital Partners LP 499,004 3.02%
AlphaOne Investment Services LLC 198,157 1.20%
Turner Investments LP 143,303 0.87%
Renaissance Technologies LLC 84,113 0.51%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
BIOGEN INC
CELGENE CORPORATI..
ABBVIE INC
ASTRAZENECA PLC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
INDIVIOR PLC
CHONGQING ZHIFEI ..
-
CELLDEX THERAPEUT..
THERAVANCE INC
WALVAX BIOTECHNOL..
-
GREEN CROSS CORP
AMAG PHARMACEUTIC..
MEDY TOX INC
ARIAD PHARMACEUTI..
Sector Pharmaceuticals
Cardiome Pharma Corp. : Connections
ProStrakan Group Plc
BC Advantage Funds (VCC) Ltd.
Licensing Executives Society
Nventa Biopharmaceuticals Corp.
American Society for Pharmacology & Experimental Therapeutic
Richardson Capital Ltd.
Premier's Technology Council
Michael Smith Foundation for Health Research
ESSA Pharma, Inc.
The Institute of Electrical & Electronics Engineers, Inc.
enGene, Inc.
The American Physiological Society
MedGenesis Therapeutix, Inc.
ATDC Seed Capital Fund LLC
Institute of Corporate Directors
Canadian Public Accountability Board
Vancouver Aquarium
viDA Therapeutics, Inc.
Trevi Therapeutics, Inc.
British Columbia Innovation Council
Kearny Venture Partners
Beth Israel Deaconess Medical Center, Inc.
Company contact information
Cardiome Pharma Corp.
6190 Agronomy Road
Suite 405
Vancouver, BC V6T 1Z3

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2015 People , Fundamentals and Ownership   
Dynamic quotes  
ON
| OFF